{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:59:24Z","timestamp":1791158364391,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0002-9343(02)01276-7","type":"journal-article","created":{"date-parts":[[2002,11,12]],"date-time":"2002-11-12T12:32:32Z","timestamp":1037104352000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"special_numbering":"S","title":["\u03b2-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities"],"prefix":"10.1016","volume":"113","author":[{"given":"Derek","family":"LeRoith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(02)01276-7_BIB1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/edrv.19.4.0338","article-title":"The genetic basis of type 2 diabetes mellitus","volume":"19","author":"Gerich","year":"1998","journal-title":"Endocr Rev"},{"issue":"suppl A","key":"10.1016\/S0002-9343(02)01276-7_BIB2","first-page":"8","article-title":"Pathogenesis of type 2 diabetes","volume":"12","author":"Lebovitz","year":"2000","journal-title":"Drug Benefit Trends"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/clinchem\/45.8.1339","article-title":"Type 2 diabetes","volume":"45","author":"Lebovitz","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8529(05)70273-5","article-title":"Tactics for type II diabetes","volume":"26","author":"Riddle","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB5","series-title":"Bailli\u00e8re\u2019s Clinical Endocrinology and Metabolism","first-page":"1007","article-title":"Insulin action and substrate competition","author":"Groop","year":"1993"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/BF00400814","article-title":"Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus","volume":"36","author":"Groop","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2337\/diacare.19.4.394","article-title":"Fatty acids and insulin resistance","volume":"19","author":"Boden","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB8","series-title":"Endocrinology","article-title":"Management of type 2 diabetes","author":"Bergenstal","year":"2001"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB9","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"issue":"6A","key":"10.1016\/S0002-9343(02)01276-7_BIB10","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(00)00336-3","article-title":"The importance of the \u03b2-cell in the pathogenesis of type 2 diabetes mellitus","volume":"108","author":"Kahn","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dmr.5610060101","article-title":"Diabetes mellitus in the Pima Indians","volume":"6","author":"Knowler","year":"1990","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. prospective diabetes study 16","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"suppl","key":"10.1016\/S0002-9343(02)01276-7_BIB16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0168-8227(98)00038-2","article-title":"Assessing the potential for \u03b1-glucosidase inhibitors in prediabetic states","volume":"40","author":"Holman","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2337\/diab.45.11.1572","article-title":"Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM","volume":"45","author":"Berkovitz","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB19","first-page":"247","article-title":"The key role of islet dysfunction in type II diabetes mellitus","volume":"18","author":"Porte","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diab.40.2.166","article-title":"\u03b2-Cells in type II diabetes mellitus","volume":"40","author":"Porte","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","article-title":"Triggering and amplifying pathways of regulation of insulin secretion by glucose","volume":"49","author":"Henquin","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/rp.56.1.47","article-title":"Of mice and men","volume":"56","author":"Aguilar-Bryan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/BF03401827","article-title":"The molecular mechanism of the insulin-mimetic\/sensitizing activity of the antidiabetic sulfonylurea drug amaryl","volume":"6","author":"M\u00fcller","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/diacare.13.6.676","article-title":"Evening insulin strategy","volume":"13","author":"Riddle","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diabetes.50.8.1683","article-title":"Glucose induces \u03b2-cell apoptosis via upregulation of the Fas receptor in human islets","volume":"50","author":"Maedler","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB26","first-page":"413","article-title":"Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus","volume":"44","author":"Kruszynska","year":"1996","journal-title":"J Invest Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/rp.56.1.175","article-title":"Intracellular organization of insulin signaling and GLUT4 translocation","volume":"56","author":"Watson","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB28","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2337\/diabetes.50.10.2296","article-title":"Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes","volume":"50","author":"Shintani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1056-8727(01)00188-X","article-title":"Hexosamines as mediators of nutrient sensing and regulation in diabetes","volume":"16","author":"McClain","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB30","doi-asserted-by":"crossref","first-page":"31099","DOI":"10.1074\/jbc.M104115200","article-title":"Activation of the hexosamine pathway leads to deterioration of pancreatic \u03b2-cell function through the induction of oxidative stress","volume":"276","author":"Kaneto","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB31","series-title":"Current Therapy of Diabetes Mellitus","first-page":"108","article-title":"Insulin therapy in type 2 diabetes mellitus","author":"Skyler","year":"1998"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/diab.45.3.273","article-title":"Are the \u03b2-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?","volume":"45","author":"Prentki","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB33","first-page":"101","article-title":"Molecular biology of adenosine triphosphate-sensitive potassium channels","volume":"20","author":"Aguilar-Bryan","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01228297","article-title":"Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment","volume":"18","author":"Kosaka","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","article-title":"The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus","volume":"34","author":"Garvey","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1965.tb34800.x","article-title":"The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus","volume":"131","author":"Randle","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4158\/EP.7.1.44","article-title":"Free fatty acids\u2014the link between obesity and insulin resistance","volume":"7","author":"Boden","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2337\/diab.46.3.393","article-title":"Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic \u03b2-cell line INS-1","volume":"46","author":"Brun","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB39","unstructured":"Ginsburg HN. Dyslipidemia and diabetes mellitus: pathophysiology and treatment"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/diab.46.6.983","article-title":"Skeletal muscle triglyceride levels are inversely related to insulin action","volume":"46","author":"Pan","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2337\/diacare.24.5.933","article-title":"Skeletal muscle triglyceride","volume":"24","author":"Kelley","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","article-title":"Minireview","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB43","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0021-9150(00)00755-3","article-title":"Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men","volume":"157","author":"Chu","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB46","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9343(02)01276-7_BIB48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2001-14948","article-title":"Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes","volume":"33","author":"Skurk","year":"2001","journal-title":"Horm Metab Res"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302012767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302012767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:22:25Z","timestamp":1757578945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934302012767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0002934302012767"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(02)01276-7","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(02)01276-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}